Barry Goldman, MD
Dermatology · New York, NYNPI 1831139856
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $29,750 of the $42,215 with a category attached, or 70.5%. AbbVie accounts for 79.9% of it on its own, with 29 other manufacturers making up the rest. Reporting peaked in 2019 at $35,376 and has fallen 93.4% since, to $2,347 in 2025. Among dermatology clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 259 payments — averaging $162.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$34K
- Dermira, Inc.$2K
- Johnson & Johnson$1K
- Regeneron Healthcare Solutions, Inc.$583
- Sanofi$579
- Amgen$448
- plus $3K from 24 others
What the payments were for
- Consulting fees$29,75070%
- Speaking & faculty fees$2,0005%
- Travel & lodging$2,4686%
- Food & beverage$7,79418%
- Education$2030%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 69 | $33,748 |
| Dermira, Inc. | 4 | $2,182 |
| Johnson & Johnson | 36 | $1,397 |
| Regeneron Healthcare Solutions, Inc. | 17 | $583 |
| Sanofi | 18 | $579 |
| Amgen | 16 | $448 |
| Incyte Corporation | 10 | $445 |
| Novartis | 18 | $396 |
| Galderma Laboratories, L.p. | 7 | $362 |
| UCB, Inc. | 7 | $256 |
| Botanix SB Inc | 7 | $243 |
| Almirall LLC | 3 | $239 |
| Lilly USA, LLC | 5 | $222 |
| Sun Pharmaceutical Industries Inc. | 5 | $210 |
| LNHC, Inc | 2 | $149 |
| Strata Skin Sciences, Inc. | 5 | $138 |
| E.r. Squibb & Sons, L.L.C. | 5 | $108 |
| LEO Pharma Inc. | 4 | $105 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 5 | $95 |
| Dermavant Sciences, Inc. | 2 | $51 |
| Organon | 2 | $48 |
| Solta Medical, A Division Of Bausch Health US, LLC | 2 | $36 |
| Pfizer | 2 | $33 |
| Bristol Myers Squibb | 1 | $25 |
| Journey Medical Corporation | 1 | $22 |
| Arcutis Biotherapeutics, Inc. | 1 | $22 |
| Medtronic | 1 | $19 |
| VYNE Pharmaceuticals Inc. | 1 | $19 |
| Prugen, Inc. Pharmaceuticals | 2 | $19 |
| Merz North America, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$42,215 in reported general payments places this provider in the 90th percentile of 1,151 dermatology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ketoconazole | 26 | $515 |
| Triamcinolone Acetonide | 30 | $154 |
Paid to pharmacies, not to this prescriber.
Other dermatology in New York
- Alexandra GolantNew York$3.6M
- David CohenNew York$3M
- Michael CameronNew York$2.6M
- Saakshi KhattriNew York$2.4M
- Amy WechslerNew York$2.4M
- Joshua ZeichnerNew York$2.1M
- Emma GuttmanNew York$1.7M
- George HanNew York$1.6M
- Amy SpizuocoNew York$1.3M
- Andrew AlexisNew York$834K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.